|
|
|
|
| LEADER |
02207nmm a2200301 u 4500 |
| 001 |
EB002005512 |
| 003 |
EBX01000000000000001168412 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
211122 ||| eng |
| 020 |
|
|
|a 9781119654803
|
| 100 |
1 |
|
|a Balamurugan, S.
|e [editor]
|
| 245 |
0 |
0 |
|a Computation in bioinformatics
|h Elektronische Ressource
|b multidisciplinary applications
|c Edited by S. Balamurugan, Anand Krishnan, Dinesh Goyal, Balakumar Chandrasekaran and Boomi Pandi
|
| 250 |
|
|
|a First edition
|
| 260 |
|
|
|a Hoboken, NJ
|b Wiley
|c 2021
|
| 300 |
|
|
|a xiv, 325 Seiten
|
| 700 |
1 |
|
|a Krishnan, Anand
|e [editor]
|
| 700 |
1 |
|
|a Goyal, Dinesh
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b WILOB
|a Wiley Online Books
|
| 490 |
0 |
|
|a Artificial intelligence and soft computing for industrial transformation
|
| 028 |
5 |
0 |
|a 10.1002/9781119654803
|
| 776 |
|
|
|z 9781119654711
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781119654803
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 570.285
|
| 650 |
|
4 |
|a Bioinformatics
|
| 650 |
|
4 |
|a Computational biology
|
| 520 |
|
|
|a Bioinformatics is a platform between the biology and information technology and this book provides readers with an understanding of the use of bioinformatics tools in new drug design. The discovery of new solutions to pandemics is facilitated through the use of promising bioinformatics techniques and integrated approaches. This book covers a broad spectrum of the bioinformatics field, starting with the basic principles, concepts, and application areas. Also covered is the role of bioinformatics in drug design and discovery, including aspects of molecular modeling. Some of the chapters provide detailed information on bioinformatics related topics, such as silicon design, protein modeling, DNA microarray analysis, DNA-RNA barcoding, and gene sequencing, all of which are currently needed in the industry. Also included are specialized topics, such as bioinformatics in cancer detection, genomics, and proteomics. Moreover, a few chapters explain highly advanced topics, like machine learning and covalent approaches to drug design and discovery, all of which are significant in pharma and biotech research and development.
|